Literature DB >> 2948906

Co-expression of CD4 and CD8 molecules and de novo expression of MHC class II antigens on activated rat T cells.

D J Bevan, P M Chisholm.   

Abstract

Rat T-cell populations were analysed for their surface expression of CD4, CD8 and class II MHC antigens using monoclonal antibodies (McAbs) W3/25, Ox8 and Ox6 in immunofluorescence and immunoenzyme cytochemistry. Resting T cells expressed either CD4 (W3/25) or CD8 (Ox8) molecules, but not both, and did not express class II MHC antigens. In contrast, when purified T cells were stimulated by Con A or by alloantigens in a mixed lymphocyte reaction (MLR), over 60% of the cells expressed class II MHC antigens after 48-72 hr. The expression of class II MHC antigens by the T-cell blasts was transient and no longer evident after 96 hr of activation. In addition, T cells activated by either alloantigen or lectin expressed CD4 (W3/25) and CD8 (Ox8) molecules simultaneously: 30% of cells activated in MLR and 50% of Con A-activated cells expressed both markers within 48 hr of activation. The overlapping of the CD4- and CD8-positive subpopulations within the T-cell population was inferred from the results of staining for each marker separately and confirmed using a double-immunoenzyme staining method.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2948906      PMCID: PMC1453336     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  18 in total

1.  Coexpression of T4 and T8 on peripheral blood T cells demonstrated by two-color fluorescence flow cytometry.

Authors:  M L Blue; J F Daley; H Levine; S F Schlossman
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

2.  "Panning" for lymphocytes: a method for cell selection.

Authors:  L J Wysocki; V L Sato
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

3.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

Review 4.  Functions of rat T-lymphocyte subsets isolated by means of monoclonal antibodies.

Authors:  D W Mason; R P Arthur; M J Dallman; J R Green; G P Spickett; M L Thomas
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

5.  Alkaline phosphatase and peroxidase for double immunoenzymatic labelling of cellular constituents.

Authors:  D Y Mason; R Sammons
Journal:  J Clin Pathol       Date:  1978-05       Impact factor: 3.411

6.  Demonstration of the stability of the membrane phenotype of T helper cells after priming and boosting with a hapten-carrier conjugate.

Authors:  G P Spickett; D W Mason
Journal:  Eur J Immunol       Date:  1983-09       Impact factor: 5.532

7.  A novel cell type carrying both Th and Tc/s markers in the blood of cyclosporine-treated, allografted rats.

Authors:  U Godden; J Herbert; R D Stewart; B Roser
Journal:  Transplantation       Date:  1985-06       Impact factor: 4.939

8.  Specific binding of alloantigens to T cells activated in the mixed lymphocyte reaction.

Authors:  Z Nagy; B E Elliott; M Nabholz; P H Krammer; B Pernis
Journal:  J Exp Med       Date:  1976-03-01       Impact factor: 14.307

9.  Ia-bearing T lymphocytes in man. Their identification and role in the generation of allogeneic helper activity.

Authors:  S M Fu; N Chiorazzi; C Y Wang; G Montrazeri; H G Kunkel; H S Ko; A B Gottlieb
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

10.  Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express Ia-like antigens.

Authors:  R L Evans; T J Faldetta; R E Humphreys; D M Pratt; E J Yunis; S F Schlossman
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

View more
  16 in total

Review 1.  T cell-mediated antigen presentation: a potential mechanism of infectious tolerance.

Authors:  M D Mannie
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

2.  Phenotypic analysis of peripheral CD4+ CD8+ T cells in the rat.

Authors:  E Kenny; D Mason; A Pombo; F Ramírez
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

3.  Recirculation of lymphocyte subsets (CD5+, CD4+, CD8+, SBU-T19+ and B cells) through gut and peripheral lymph nodes.

Authors:  W G Kimpton; E A Washington; R N Cahill
Journal:  Immunology       Date:  1989-01       Impact factor: 7.397

4.  Circulating CD4+CD8+ cells in myasthenia gravis: supplementary immunological parameter for long-term prognosis.

Authors:  M Matsui; H Fukuyama; I Akiguchi; M Kameyama
Journal:  J Neurol       Date:  1989-09       Impact factor: 4.849

5.  Immunosuppression with cyclosporin A alters the thymic microenvironment.

Authors:  M Kanariou; R Huby; H Ladyman; M Colic; G Sivolapenko; I Lampert; M Ritter
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

6.  In vivo imaging of rat lymphocytes with an indium 111-labelled anti-T cell monoclonal antibody: a comparison with indium 111-labelled lymphocytes.

Authors:  I Loutfi; P M Chisholm; D Bevan; J P Lavender
Journal:  Eur J Nucl Med       Date:  1990

7.  Activated rat T cells synthesize and express functional major histocompatibility class II antigens.

Authors:  C P Broeren; M H Wauben; M A Lucassen; M Van Meurs; P J Van Kooten; C J Boog; E Claassen; W Van Eden
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

8.  Acquisition of cell-mediated immunity to Leishmania. I. Primary T-cell activation detected by IL-2 receptor expression.

Authors:  P M Kaye
Journal:  Immunology       Date:  1987-07       Impact factor: 7.397

9.  Quantification of proliferating lymphocyte subsets appearing in the intestinal lymph and the blood.

Authors:  K H Thielke; R Pabst; H J Rothkötter
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

10.  BB-DR/Edinburgh: a lymphopenic, non-diabetic subline of BB rats.

Authors:  S Joseph; A G Diamond; W Smith; J D Baird; G W Butcher
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.